וובינר "מה חדש בטיפול בזיהומים בדרכי השתן?" – ד"ר שירה חתומי | מתוך וובינר לרוקחים 27.9.23
לפניכם הרצאתה של ד"ר שירה חתומי, מומחית בכירורגיה אורולוגית, מנהלת מרפאת כללית מגדל המאה, ת"א, מתוך וובינר לרוקחים שהתקיים
וובינר "חידושים במניעת זיהומים בדרכי השתן" – ד"ר שחר אהרוני | מתוך מפגש האגודה לגיל המעבר 5.9.23
לפניכם הרצאתו של ד"ר שחר אהרוני, מנהל היחידה לאורולוגיה תפקודית, מרכז רפואי רבין, מתוך מפגש האגודה לגיל המעבר שהתקיים
Cystitis and Utipro® Plus: Real-World Evidence
Abstract Background: The emergence of drug resistance in the etiological agents of uncomplicated urinary tract infections (UTIs) emphasizes the
Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis
Abstract Background: In the era of antibiotic resistance, an antibiotic-sparing approach presents an interesting alternative treatment of uncomplicated cystitis
Clinical Experience with a Medical Device Containing Xyloglucan, Hibiscus, and Propolis for the Control of Acute Uncomplicated Urinary Tract Infection-like Symptoms
Abstract Background: The development of drug resistance among causative agents has resulted in the need to change the paradigm
Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study
Abstract Aim: To evaluate the efficacy of a medical device containing xyloglucan, hibiscus and propolis in the management of recurrent
Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults.
Abstract Background: A medical device containing xyloglucan-gelose-hibiscus-propolis (referred to hereafter as xyloglucan + gelose) acts as a mucosal barrier protector
Efficacy and Safety of a Medical Device versus Placebo in the Early Treatment of Patients with Symptoms of Urinary Tract Infection: A Randomized Controlled Trial
Abstract Background: The objective of the study was to analyze the efficacy and safety of a medical device containing
A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial.
Abstract Objective: To assess the efficacy and safety of a new medical device (MD; a capsule whose main component is
Cystitis and Utipro® Plus: Real-World Evidence
Abstract Background: The emergence of drug resistance in the etiological agents of uncomplicated urinary tract infections (UTIs) emphasizes the need to shift the
Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis
Abstract Background: In the era of antibiotic resistance,
Clinical Experience with a Medical Device Containing Xyloglucan, Hibiscus, and Propolis for the Control of Acute Uncomplicated Urinary Tract Infection-like Symptoms
Abstract Background: The development of drug resistance among
Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study
Abstract Aim: To evaluate the efficacy of a medical
Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults.
Abstract Background: A medical device containing xyloglucan-gelose-hibiscus-propolis (referred to
Efficacy and Safety of a Medical Device versus Placebo in the Early Treatment of Patients with Symptoms of Urinary Tract Infection: A Randomized Controlled Trial
Abstract Background: The objective of the study was
A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial.
Abstract Objective: To assess the efficacy and safety of
